# ScoreItem: Densitometria - T-Score Coluna Lombar

**ID:** `c77cedd3-2800-784a-8fdd-1245aa35701e`
**FullName:** Densitometria - T-Score Coluna Lombar (Exames - Imagem)
**Unit:** score

**Preparation Metadata:**
- Quality Grade: **GOOD**
- Total Chunks: 30 de 15 artigos
- Avg Similarity: 0.576

---

## Contexto

Você é um especialista em medicina funcional integrativa e está contribuindo com o **Escore Plenya** — um escore completo de análise de saúde que avalia todos os aspectos da saúde, performance e longevidade humana. Cada ScoreItem representa um parâmetro clínico, laboratorial, genético, comportamental ou histórico que compõe esse escore.

Seu papel é gerar conteúdo clínico de alta qualidade para enriquecer cada parâmetro do escore com relevância clínica, orientação ao paciente e conduta prática.

**Regras inegociáveis:**
- Use **apenas** o conhecimento médico real consolidado e os dados presentes nos chunks científicos abaixo
- **Não alucine, não invente** dados, estudos, estatísticas ou referências que não estejam nos chunks ou no seu conhecimento médico estabelecido
- Se um dado específico não constar nos chunks e não for do seu conhecimento consolidado, **não o inclua**
- Seja preciso: prefira omitir a inventar

## Instrução

Com base nos chunks científicos abaixo, gere as respostas em formato JSON.

**O JSON deve obrigatoriamente conter o campo `score_item_id` com o valor `c77cedd3-2800-784a-8fdd-1245aa35701e`.**

```json
{
  "score_item_id": "c77cedd3-2800-784a-8fdd-1245aa35701e",
  "clinical_relevance": "Texto técnico para médicos (1000-5000 chars): definição fisiológica precisa, valores de referência e interpretação, fisiopatologia resumida, dados epidemiológicos com números concretos, estratificação de risco baseada em evidências.",
  "points": 1,
  "patient_explanation": "Texto simples para pacientes (500-1000 chars): o que é este parâmetro sem jargões, por que é importante para a saúde, o que valores alterados podem significar. Tom tranquilizador e educativo.",
  "conduct": "Conduta clínica em Markdown (1000-5000 chars): investigação complementar necessária, critérios de encaminhamento a especialistas, intervenções baseadas em evidências. Use bullet points, seções e negrito."
}
```

**Regras para `points` (1-50):**
- Baixo impacto clínico: 1-9 pts
- Alto impacto clínico: 10-19 pts
- Alto impacto em mortalidade: 20-50 pts
- Critérios: gravidade/mortalidade (40%), prevalência (30%), intervencionabilidade (30%)

---

### Contexto Científico

**ScoreItem:** Densitometria - T-Score Coluna Lombar (Exames - Imagem)
**Unidade:** score

**30 chunks de 15 artigos (avg similarity: 0.576)**

### Chunk 1/30
**Article:** Diretrizes brasileiras para o diagnóstico e tratamento da osteoporose em mulheres na pós-menopausa (2017)
**Journal:** Revista Brasileira de Reumatologia
**Section:** abstract | **Similarity:** 0.674

Diretrizes da Sociedade Brasileira de Reumatologia para diagnóstico e tratamento da osteoporose. Define critérios diagnósticos por T-score, indicações de tratamento farmacológico, metas terapêuticas e monitoramento. Inclui recomendações específicas para população brasileira considerando fatores de risco locais.

---

### Chunk 2/30
**Article:** Classification of Osteoporosis (2023)
**Journal:** Indian Journal of Orthopaedics
**Section:** abstract | **Similarity:** 0.664

The World Health Organization devised a BMD classification system utilizing T-scores for specific populations. T-score is defined as patient measured BMD value minus the reference BMD value divided by the reference standard deviation. T-scores apply to postmenopausal women and men aged 50 years and older. Conversely, Z-scores are preferred for premenopausal women, adults under 50, and children. The diagnostic approach emphasizes that bone mineral density measurement alone cannot diagnose osteoporosis in men under 50 years. The FRAX algorithm supplements BMD testing by incorporating clinical fracture risk predictors. Treatment is recommended when FRAX indicates a 10-year hip fracture probability of at least 3% or major osteoporotic fracture risk exceeding 20%.

---

### Chunk 3/30
**Article:** Osteopenia (2025)
**Journal:** StatPearls [Internet]
**Section:** abstract | **Similarity:** 0.658

Osteopenia refers to reduced bone mineral density below normal values without fulfilling the diagnostic threshold for osteoporosis, measured via dual-energy x-ray absorptiometry (DXA). T-Score Classification: Normal within 1 SD, Osteopenia between -1.0 and -2.5, Osteoporosis less than -2.5. Clinical significance: approximately 48-56% of fragility fractures in postmenopausal women occur in individuals with osteopenia-level bone density. Management: Low-to-moderate risk receives nonpharmacologic management (exercise, calcium/vitamin D supplementation). High risk receives pharmacologic therapy when 10-year hip fracture probability reaches 3% or major osteoporotic fracture risk exceeds 20% via FRAX assessment. Prevalence: 43.3 million American adults over 50 have osteopenia, affecting approximately 50% of women and 30% of men.

---

### Chunk 4/30
**Article:** Official Positions of the International Society for Clinical Densitometry (2013)
**Journal:** Journal of Clinical Densitometry
**Section:** abstract | **Similarity:** 0.641

Comprehensive guidelines for bone densitometry interpretation and clinical application. Addresses T-score measurement sites, precision assessment, serial monitoring intervals, and fracture risk prediction. Recommends lumbar spine L1-L4 as primary measurement site with specific exclusion criteria for vertebral artifacts.

---

### Chunk 5/30
**Article:** Assessment of fracture risk and its application to screening for postmenopausal osteoporosis (1994)
**Journal:** WHO Technical Report Series
**Section:** abstract | **Similarity:** 0.597

World Health Organization criteria for osteoporosis diagnosis based on bone mineral density measurements. Defines T-score thresholds: normal (≥-1.0 SD), osteopenia (-1.0 to -2.5 SD), osteoporosis (≤-2.5 SD). Established BMD as primary diagnostic tool for fracture risk assessment.

---

### Chunk 6/30
**Article:** FRAX and the assessment of fracture probability in men and women from the UK (2008)
**Journal:** Osteoporosis International
**Section:** abstract | **Similarity:** 0.594

Development and validation of FRAX algorithm integrating BMD T-scores with clinical risk factors for fracture probability assessment. Demonstrates superior fracture prediction when combining T-score with age, prior fractures, family history, and other risk factors. Establishes intervention thresholds based on 10-year fracture probability.

---

### Chunk 7/30
**Article:** Suplementação I (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.591

ção de cálcio isolado na menopausa
- Estudos (2008) indicam que cálcio isolado não resolve osteoporose e pode aumentar risco de IAM.
- Plausibilidade: déficit hormonal na menopausa não se corrige apenas com cálcio; é necessário ativar osteoblastos e mecanismos regulatórios.
- Quando considerar cálcio: ingesta dietética insuficiente, em combinação com cofatores e estratégia integrada.
### 12. Vitamina K2 (MK-7): papel, sinergias e evidências
- K2 (especialmente MK-7; também MK-4) frequentemente associada à vitamina D; não é “essencial” para a D funcionar, mas são sinérgicas e com funções distintas.
- Evidências: redução de perda de cálcio (~50% previsto, estudo de 1995); K2 isolada (mesmo com cálcio, D, magnésio, boro) não resolve osteopenia/osteoporose sozinha.
- Resultados dependem de hábitos, exercício com impacto, possível reposição hormonal; em alguns casos, bisfosfonatos.

---

### Chunk 8/30
**Article:** Association between Serum Total Testosterone Level and Bone Mineral Density in Middle-Aged Postmenopausal Women (2022)
**Journal:** International Journal of Endocrinology
**Section:** results | **Similarity:** 0.589

whennon-linearitywasidentiEed.StatisticalanalyseshwereperformedusingEmpowerStatsandRsoftware(ver-hsion3.4.3).StatisticalsigniEcancewassetatP<0.05.3.ResultsBaselinecharacteristicsforthe1,058womenincludedinourstudygrouparepresentedinTable1byquartileofserumtotalTlevel.ComparedtotheQ4group,womenwithlowerhserumtotalTlevelshadahigherlevelofbloodureanitrogenhandlowerBMIandlumbarBMD.AsshowninTable2,therehwasapositiveassociationbetweenserumtotalTlevelandhlumbarBMDinallthreeregressionmodels(model1:β1.65,95%conEdenceinterval(CI)0.74–2.56;model2:β,1.43;95%CI,0.54–2.32;andmodel3:β,1.07;95%CI,0.17–1.97).PvaluefortrendwassigniEcantforthethreeregressionmodelsacrossthequartilegroupsofserumTtotallevels.OnhsubgroupanalysisstratiEedbyBMI(Table3),thepositiveassociationremainedsigniEcantforthe25–29.9kg/m2BMIgroup(β,2.60;95%CI,0.73–4.47)butnotforthe<25kg/m2BMIgroup(β,0.20;95%CI,−1.81–2.21)orthe≥30kg/m2BMIgroup(β,0.27;95%CI,−0.93–1.47).However,thepositiveassociationwasnolongersigniEc

---

### Chunk 9/30
**Article:** Terapia de Reposição Hormonal Feminina II (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.585

; divulgação em 2002; seguimento planejado de 7–10 anos e acompanhamento de 13 anos.
- Amostra total >16.000; ~50% em terapia hormonal; critérios de exclusão relacionados a fogachos responderam por ~90%.
- Participantes entre 50–79 anos; média de idade 63 anos; em média 12 anos pós-menopausa ao iniciar tratamento, reduzindo a aplicabilidade à janela precoce.
- Premarin contém 10 tipos de estrogênio, apenas 3 análogos ao humano; medroxiprogesterona tem potência ~3 vezes maior no receptor de progesterona, fatores que podem influenciar efeitos e segurança.
- Valor de referência de significância estatística nos gráficos mencionado como “10+”, contextualizando interpretações.
**Achados Adicionais**
- Há mais de 1.000.000 fraturas/ano nos EUA; pelo menos 1/4 devido à osteoporose.
- 15% das mulheres que fraturam morrem no primeiro ano e 75% perdem independência após a fratura.
- DNA FEN-AID com 42 biomarcadores epigenéticos do envelhecimento.

---

### Chunk 10/30
**Article:** Suplementação I (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.582

ozinha.
- Resultados dependem de hábitos, exercício com impacto, possível reposição hormonal; em alguns casos, bisfosfonatos.
- Metabolismo da glicose: redução de glicemia pós-prandial em homens jovens após 1 semana; efeito discreto.
- Câncer: deficiência associada à maior malignidade de câncer de próstata (via osteocalcina subcarboxilada); evidência de inibição em carcinoma hepatocelular.
- Longevidade: estudo de Rotterdam (2004) associa maior ingesta à maior sobrevida (~7 anos), menor risco relativo de DCV (−57%), menos calcificação de aorta (−52%), menor mortalidade geral (−26%).
- Fontes alimentares: natto (soja fermentada) é a mais rica; também fígado de ganso e queijos (emmental, moles); atenção a intolerâncias e autoimunes.
- Aviso preliminar: considerar interações com anticoagulantes cumarínicos; detalhamento em cardiologia futura.

---

### Chunk 11/30
**Article:** Association between Serum Total Testosterone Level and Bone Mineral Density in Middle-Aged Postmenopausal Women (2022)
**Journal:** International Journal of Endocrinology
**Section:** other | **Similarity:** 0.577

.15<0.001Serumcalcium(mmol/L)2.37±0.092.35±0.082.35±0.082.36±0.100.114Lumbarbonemineraldensity(mg/cm2)951.3±139.5986.1±151.8992.5±149.01009.6±147.6<0.001Mean±SDforcontinuousvariables:pvaluewascalculatedbyweightedlinearregressionmodel.%forcategoricalvariables:pvaluewascalculatedbytheweightedchi-squaretest.

---

### Chunk 12/30
**Article:** Association between Serum Total Testosterone Level and Bone Mineral Density in Middle-Aged Postmenopausal Women (2022)
**Journal:** International Journal of Endocrinology
**Section:** results | **Similarity:** 0.576

included:age,race,bodymassindex(BMI),educationhlevel,incometopovertyratio,moderateactivities,agesincehmenopause,bloodureanitrogen,serumuricacid,totalhprotein,serumphosphorus,andserumcalcium..edetailedhprocessforacquisitionofthesevariablescanbefoundonthehNHANESwebsite(https://www.cdc.gov/nchs/nhanes/).2.3.StatisticalAnalyses.Accordingtotheanalyticalguide-lineeditedbyNCHS,dataanalysestookintoaccounthsamplingweights.WeightedmultipleregressionanalyseshwerethenusedtoevaluatetheassociationbetweenserumhtotalTlevelandlumbarBMD..reemodelswerecon-hstructedtoprovidestatisticalinference:model1,noad-justmentforcovariates;model2,adjustmentforageandrace;andmodel3,adjustmentforallcovariates.WefurtherhperformedsmoothcurveEttingtoaddresspotentialnon-hlinearityandperformedatwo-piecewiselinearregressionhmodelwhennon-linearitywasidentiEed.StatisticalanalyseshwereperformedusingEmpowerStatsandRsoftware(ver-hsion3.4.3).StatisticalsigniEcancewassetatP<0.05.3.ResultsBaselinecharacteristicsforthe1,058womeninclud

---

### Chunk 13/30
**Article:** Association between Serum Total Testosterone Level and Bone Mineral Density in Middle-Aged Postmenopausal Women (2022)
**Journal:** International Journal of Endocrinology
**Section:** discussion | **Similarity:** 0.576

rforHealthStatistics,andallparticipantshprovidedwrittenconsentfortheuseoftheirdataforresearch.Forourstudy,wepooleddatafromtheNHANESbe-tween2011and2016..estudypopulationwaslimitedtohpostmenopausalwomenaged40–59years(n�1,320).WeexcludedindividualswithmissingserumtotalTlevelh(n�74)orlumbarBMD(n�174)data,aswellasthosewithaserumtotalTlevelabovetheupperlimitofnormal(70ng/hdL;n�14).Afterselection,1,058womenwereincludedinourEnalanalysis(Figure1).2.2.StudyVariables..eisotopedilutionliquidchroma-tographytandemmassspectrometrymethodwasusedtomeasuretheconcentrationofserumtotalTlevels,basedonthereferencemethodoftheNationalInstituteforStandardsandTechnology[14].Dual-energyX-rayabsorptiometrywashusedtoquantifylumbarBMD,acquiredusingaHologichDiscoverymodelAdensitometer..efollowingcovariateshwereincluded:age,race,bodymassindex(BMI),educationhlevel,incometopovertyratio,moderateactivities,agesincehmenopause,bloodureanitrogen,serumuricacid,totalhprotein,serumphosphorus,andserumcalcium..edetailed

---

### Chunk 14/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.575

opause(y)49.69±3.150.51±3.549.43±2.350.15±3.60.76Historyoffracture(%)60.8%29.8%32.0%0<0.001Physicalexercise(%)No49.141.745.618.8<0.001Low31.429.333.532.80.023High19.529.020.948.4<0.001Milkconsumptionhigh(%)No41.635.738.730.3<0.001Low34.639.537.946.4<0.001High23.824.823.423.30.417DHEA(ng/ml)32.51±12.842.64±12.834.97±16.248.45±10.60.042PTH(pg/ml)44.5(29.5–57.2)40.5(29.3–55.8)34.5(28.3–42.9)45.4(32.9–58.5)0.09225OHD(ng/ml)21.61±8.121.2(15.4–28.5)23.97±9.524.3(19.1–27.7)20.54±7.318.3(13.9–22.7)25.87±12.226.4(19.3–35.3)0.024CTX(pg/ml)380.83±145.6425.89±183.19338.43±159.7372.60±210.30.364PINP(ng/ml)36.76±15.248.15±17.038.62±11.444.03±16.50.085Follistatin(ng/ml)18.76±4.814.93±4.018.97±6.113.0±4.90.027Myostatin(ng/ml)3.07±1.33.70±1.32.75±1.63.99±1.50.178BDNF(ng/ml)22.67±13.330.75±10.628.74±7.830.80±10.90.265Oxytocin(pg/ml)398.3(173.2–662.6)425.8(200.2–702.3)500.4(289.3–823.4)612.7(356.2–1276.5)0.022BMD(g/cm2)LumbarSpine0.703±0.150.695±0

---

### Chunk 15/30
**Article:** Estimations of bone mineral density defined osteoporosis prevalence and cutpoint T-score for defining osteoporosis among older Chinese population: a framework based on relative fragility fracture risks (2022)
**Journal:** Quantitative Imaging in Medicine and Surgery
**Section:** abstract | **Similarity:** 0.571

The research proposes adjusted diagnostic thresholds for Chinese populations. The investigators estimate osteoporosis prevalence rates based on the assumption that fragility fracture risk in older Chinese individuals is approximately half that of Caucasian counterparts. Estimated osteoporosis prevalence (age ≥50 years): Chinese women: 7.5% (lumbar), 7.5% (femoral neck), 6.7% (total hip); Chinese men: 2.0% (lumbar), 3.8% (femoral neck), 3.4% (total hip). The authors recommend revised cutpoint T-scores rather than conventional WHO thresholds of −2.5 and −1.0, suggesting population-specific adjustments better reflect actual fracture risk in Chinese populations.

---

### Chunk 16/30
**Article:** Vitamina D (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.570

ia (já realizada; dose não especificada).
  - Suplementação: vitamina D (inicialmente 30.000 UI/dia), vitaminas B2 e B12, magnésio; possíveis fitoterápicos/antroposóficos (não especificados).
  - Inserir mais aqui.
- Próximos Passos/Exames:
  - Monitorar 25(OH)D visando faixa de 40–100 ng/mL conforme recomendações da ABN, com individualização por resposta clínica e laboratorial.
  - Monitorar PTH para manter próximo ao limite inferior da normalidade, evitando hiperparatireoidismo relativo ou supressão excessiva.
  - Monitorar cálcio sérico total e ionizado, fósforo, função renal; avaliar hipercalciúria periodicamente.
  - Revisar função hepática e medicamentos que interferem nas enzimas do citocromo P450 (corticoides, antiepilépticos).
  - Considerar avaliação de magnésio (preferencialmente estado intracelular), riboflavina (B2), vitamina A, zinco, função tireoidiana, perfil lipídico e hábitos alimentares.

---

### Chunk 17/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** results | **Similarity:** 0.566

BDNF(ng/ml)22.67±13.330.75±10.628.74±7.830.80±10.90.265Oxytocin(pg/ml)398.3(173.2–662.6)425.8(200.2–702.3)500.4(289.3–823.4)612.7(356.2–1276.5)0.022BMD(g/cm2)LumbarSpine0.703±0.150.695±0.060.895±0.090.886±0.08<0.001FemoralNeck0.579±0.090.612±0.100.648±0.060.659±0.100.019TotalHip0.722±0.100.748±0.110.767±0.090.816±0.130.007BMI(kg/m2)19.41±1.923.96±3.320.31±1.925.09±2.6<0.001Fatmass(kg)15.50±2.320.86±4.918.59±5.121.43±4.00.001Leanmass(kg)30.43±2.436.99±3.832.87±3.138.27±3.8<0.001ASMI(kg/m2)4.92±0.26.22±0.54.96±0.36.44±0.5<0.001OSOsteosarcopenia,OPOsteoporosis,SPSarcopenia,NonSP/NonOPNosarcopenianoosteoporosis,DHEADehydroepiandrosterone,PTHParathyroidhormone,CTXC-telopeptidecollagencrosslinks,P1NPN-terminalpropeptideoftype1collagen,BDNFBrain-derivedneurotrophicfactor,BMDBonemineraldensity,BMIBodymassindex,ASMIAppendicularskeletalmassindexDuetal.BMCGeriatrics         (2021) 21:542 Page7of10

OurresultsshowedthatvitaminDdeficiencywasverycommonintheChi

---

### Chunk 18/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** discussion | **Similarity:** 0.560

iablesOsteoporosisSarcopeniaOR(95%CI)PvalueOR(95%CI)P-valueHistoryoffragilefracture(novs.fracture)0.30(0.05–0.71)0.0060.45(0.01–0.86)0.015Physicalexercise(novs.high)0.97(0.44–3.13)0.941.07(0.24–2.51)0.69Milkconsumption(novs.high)1.39(0.57–3.34)0.466.32(1.04–38.29)0.045DHEA(ng/ml)0.75(0.61–1.05)0.060.73(0.51–0.96)0.032T20.89(0.63–1.24)0.620.78(0.44–2.22)0.72E20.67(0.33–2.65)0.580.90(0.46–3.12)0.65PTH(pg/ml)1.01(0.97–1.04)0.640.97(0.90–1.04)0.3625OHD(ng/ml)0.98(0.93–1.07)0.220.51(0.11–0.82)0.047CTX(pg/ml)1.02(0.98–1.05)0.171.02(0.92–1.12)0.78PINP(ng/ml)1.12(0.97–1.48)0.511.07(0.95–1.17)0.31Follistatin(ng/ml)1.08(0.56–2.09)0.171.66(1.19–3.57)0.022Myostatin(ng/ml)0.95(0.90–1.13)0.821.01(0.98–1.03)0.56BDNF(ng/ml)0.78(0.38–1.62)0.500.35(0.07–1.82)0.35Oxytocin(pg/ml)0.75(0.63–0.98)0.0190.88(0.57–1.01)0.14Multivariatelogisticanalysiswasperformedafteradjustingforage.DHEADehydroepiandrosterone,PTHParathyroidhormone,CTXC-telopeptidecollagenc

---

### Chunk 19/30
**Article:** Fragility Fractures and the Osteoporosis Care Gap in Women: The OSIRIS Study (2013)
**Journal:** Journal of Bone and Mineral Research
**Section:** abstract | **Similarity:** 0.552

This study documented the care gap in fragility fracture management, finding that fewer than 20% of patients with fragility fractures receive appropriate osteoporosis investigation and treatment. Fragility fractures indicate underlying bone fragility and substantially increase risk of subsequent fractures. The study emphasizes the critical need for systematic post-fracture assessment including bone densitometry and initiation of anti-osteoporotic therapy to prevent future fractures.

---

### Chunk 20/30
**Article:** Genética e Epigenética II (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.551

a elevar os níveis, seguida de reavaliação sanguínea em dois meses para ajustar a dose de manutenção (geralmente 2.000 a 5.000 UI/dia). O monitoramento é feito com o exame de 25-hidroxivitamina D, e o PTH pode servir como marcador funcional.
### 3. A Importância do Magnésio e da Vitamina K2
- **Magnésio:** A ativação da vitamina D depende de magnésio, sendo crucial prescrevê-los em conjunto. A deficiência de magnésio é generalizada no Brasil, e o exame de sangue sérico não é um bom indicador de seu status corporal. O magnésio atua como um bloqueador natural dos canais de cálcio, sendo vital para a saúde cardiovascular (hipertensão) e para modular a excitotoxicidade no sistema nervoso (ansiedade, depressão). Recomenda-se a suplementação para todos os pacientes.
- **Vitamina K2 (MK7):** Deve ser co-prescrita com a vitamina D para ajudar a direcionar o cálcio para os ossos, otimizando a saúde óssea e cardiovascular.

---

### Chunk 21/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** results | **Similarity:** 0.550

Bonemineraldensity,CTXC-telopeptidecollagencrosslinksDuetal.BMCGeriatrics         (2021) 21:542 Page6of10

fourgroupsofpostmenopausalwomenwithdifferentbonemusclestatusesandanalyzedtherelationshipsofbiomarkerswiththeriskofosteoporosisandsarcopenia.Theresultsshowedthatelevatedoxytocinlevelswereas-sociatedwithareducedriskofosteoporosis,andele-vatedDHEAlevelswereassociatedwithareducedriskofsarcopenia.However,elevatedfollistatinlevelswereassociatedwithanincreasedriskofsarcopenia.ThecurrentstudyfoundthatDHEAandoxytocinweresig-nificantlylowerinpostmenopausalwomenwithahis-toryoffragilityfracturecomparedtowomenwithoutfracture(datanotshown).Therefore,serumDHEAandfollistatinmaybebiomarkersofsarcopenia,andserumoxytocinmaybeabiomarkerofosteoporosis.Severalstudiesshowedthatphysicalexerciseinflu-encedserumlevelsoffollistatinandDHEA[33–35].Ourresultsshowedthatpostmenopausalwomenwith-outosteoporosis/sarcopeniaperformedhigherexerciselevelsthanwomenwithosteoporosis/sarcopenia.Fortheseresults,weconsider

---

### Chunk 22/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** other | **Similarity:** 0.550

I:Appendicularskeletalmassindex;AWGS:AsianWorkingGroupforSarcopenia;BDNF:Brain-derivedneurotrophicfactor;BMD:Bonemineraldensity;BMI:Bodymassindex;CI:Confidenceintervals;COPD:Chronicobstructivepulmonarydisease;CT:Computedtomography;CTX:C-telopeptidecollagencrosslinks;CV:Coefficientsofvariance;DHEA:Dehydroepiandrosterone;DXA:DualenergyX-rayabsorptiometry;E2:Estradiol;FSH:Folliclestimulatinghormone;LH:Luteinizinghormone;MRI:Magneticresonanceimaging;OR:Oddsratios;P1NP:N-terminalpropeptideoftype1collagen;PTH:Parathyroidhormone;SHBG:Sexhormone-bindingglobulin;SPPB:Shortphysicalperformancebattery;T2:Testosterone;TGF-β:Transforminggrowthfactor-beta;WHO:WorldHealthOrganization
Table4Correlationofhistoryoffragilefracture,lifestyleandserumbiomarkerswithosteoporosisorsarcopeniabyLogisticRegressionVariablesOsteoporosisSarcopeniaOR(95%CI)PvalueOR(95%CI)P-valueHistoryoffragilefracture(novs.fracture)0.30(0.05–0.71)0.0060.45(0.01–0.86)0.015Physicalexercise(novs.high)0.97(0.44–3.13)0.941.07(0.24 

---

### Chunk 23/30
**Article:** Association between Serum Total Testosterone Level and Bone Mineral Density in Middle-Aged Postmenopausal Women (2022)
**Journal:** International Journal of Endocrinology
**Section:** conclusion | **Similarity:** 0.547

variates,therewasapositiveassociationbetweentheserumtotalTlevelandlumbarBMD(β,1.07;95%conEdenceinterval,0.17–1.97).Anon-linearityinthisassociationwasidentiEed,withapointofinFectionath30ng/dL.Conclusions.SerumtotalTlevelwaspositivelyassociatedwithlumbarBMDinmiddle-agedpostmenopausalwomenuptoaTlevel>30ng/dL..erefore,increasingTlevelinwomenwithalowserumtotalTlevelmayhavebeneEcialoutcomesonbonehealth.1.BackgroundHormonestatusstronglya3ectswomen’shealthandqualityoflife,withage-associatedestrogendeEciencyandhormonalhimbalancehavingbeenimplicatedinthepathogenesisofhvariousdiseases,includingosteoporosis[1].Postmenopausalhosteoporosisisthemostcommontypeofosteoporosisandishcharacterizedbylowbonemineraldensity(BMD),whichhincreasestheriskoffractures[2,3]..ecauseofpost-hmenopausalosteoporosis,however,remainstobeclariEed.Duringanormalmenstrualcycle,theovariesproduceestrogen,androgens,andprogesterone[4].WhileestrogenhdeEciencyisgenerallyconsideredtobeassociatedwithbonelossinpostmenopausalwomen[5

---

### Chunk 24/30
**Article:** Suplementação I (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.547

alisar laudos e comparar preços de ativos com marcas como Essential para detectar discrepâncias.
- [ ] 2. Planejar prescrição de resveratrol considerando origem, forma e biodisponibilidade; priorizar poucos ativos de alta qualidade; avaliar ODF/transdérmico.
- [ ] 3. Integrar vitamina K2 (MK7/MK4) com vitamina D quando indicado; ajustar doses ao perfil do paciente e contraindicações relativas, especialmente em cardiologia.
- [ ] 4. Estruturar protocolo para osteopenia/osteoporose: considerar reposição hormonal, exercícios com impacto (pular corda, corrida leve), musculação; base nutricional com D, K2, magnésio, cálcio e boro sem promessa de “cura” isolada.
- [ ] 5. Educar pacientes sobre riscos do cálcio isolado na menopausa e propor alternativas baseadas em evidências.
- [ ] 6.

---

### Chunk 25/30
**Article:** Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis (2008)
**Journal:** Canadian Medical Association Journal
**Section:** abstract | **Similarity:** 0.545

Meta-analysis of randomized controlled trials demonstrates that bisphosphonates significantly reduce vertebral fracture risk by 40-50% and hip fracture risk by 30-40% in postmenopausal women with osteoporosis. The greatest benefit is observed in patients with prior fragility fractures. Treatment duration of 3-5 years shows optimal benefit-risk ratio, with consideration for drug holidays in lower-risk patients to minimize rare adverse events.

---

### Chunk 26/30
**Article:** Association between Serum Total Testosterone Level and Bone Mineral Density in Middle-Aged Postmenopausal Women (2022)
**Journal:** International Journal of Endocrinology
**Section:** methods | **Similarity:** 0.544

ns[10–12].Moreover,therateofbonelosshisnotablyhighintheErstfewyearsofmenopauseforhwomen[13].Accordingly,ouraiminthisstudywastohevaluatetheassociationbetweenserumtotalTlevelandlumbarBMDinmiddle-agedpostmenopausalwomenusingdatafromtheNationalHealthandNutritionExaminationhSurvey(NHANES).HindawiInternational Journal of EndocrinologyVolume 2022, Article ID 4228740, 6 pageshttps://doi.org/10.1155/2022/4228740

2.MaterialsandMethods2.1.DataSourceandStudyPopulation..eNHANESisalarge,ongoing,cross-sectional,population-levelsurveyre-gardingthehealthandnutritionstatusofanationallyrep-hresentativesampleofthenon-institutionalizedpopulationinhtheUnitedStates..eNHANESusesacomplex,stratiEed,hmultistageprobabilitysamplingdesign..esurveyprotocolshwereapprovedbytheInstitutionalReviewBoardofthehNationalCenterforHealthStatistics,andallparticipantshprovidedwrittenconsentfortheuseoftheirdataforresearch.Forourstudy,wepooleddatafromtheNHANESbe-tween2011and2016..estudypopulationwaslimitedtohpostmenopausalwomen

---

### Chunk 27/30
**Article:** Association between Serum Total Testosterone Level and Bone Mineral Density in Middle-Aged Postmenopausal Women (2022)
**Journal:** International Journal of Endocrinology
**Section:** results | **Similarity:** 0.542

enTconcentrationsandincreasedBMDinwomen[11].hMoreover,inwomenwithclassiccongenitaladrenalhy-hperplasia,theandrogenexcessprovidesaprotectivee3ectonBMD[12].OurresultsrevealedthathigherserumtotalTlevelwassigniEcantlyassociatedwithhigherlumbarBMD,uptoalevelof>30ng/dL,withthepositiveassociationnotretainedafterthispoint.ApreviousstudyhasshownthathighserumhTlevelsinwomenareassociatedwithadversehealthe3ects,hincludingtype2diabetes,polycysticovarysyndrome,andhbreastandendometrialcancers[21]..erefore,thebalancehbetweenthepotentialbeneEtsandrisksofhigherserumThlevelsneedstobecomprehensivelyconsidered.Testosteroneplaysaroleinboneformationthroughitsdirectactiononosteoblasts,viatheandrogenreceptor,ashwellashasindirecte3ectsonbonemetabolismthroughitshe3ectonvariousgrowthfactorsandcytokines[22].hMoreover,testosteronecanpromoteosteoblastdi3erentia-htionandapoptosisbyincreasingtheexpressionlevelofhandrogenreceptor[9,23].Moreover,Tcanbeconvertedtohestradiolbythearomataseenzyme,andestradiolbindstothehestr

---

### Chunk 28/30
**Article:** Association between Serum Total Testosterone Level and Bone Mineral Density in Middle-Aged Postmenopausal Women (2022)
**Journal:** International Journal of Endocrinology
**Section:** discussion | **Similarity:** 0.540

kg/m2BMIgroup(β,2.60;95%CI,0.73–4.47)butnotforthe<25kg/m2BMIgroup(β,0.20;95%CI,−1.81–2.21)orthe≥30kg/m2BMIgroup(β,0.27;95%CI,−0.93–1.47).However,thepositiveassociationwasnolongersigniEcantafteradjustingforcovariatesinsubgroupanalysisstratiEedbyraceh(Table3)..enon-linearassociationbetweenserumtotalTlevelsandlumbarBMDisshowninFigure2,withthepointofhinFectionpointat30ng/dL(Table4).ForserumtotalThlevels<30ng/dL,thee3ectsizeoftheserumtotalTlevelonBMDwas1.47(95%CI,0.19–2.75),withane3ectsizeof0.14h(95%CI,−2.15–2.44)forserumtotalTlevels>30ng/dL.4.Discussion.ekeyEndingofourstudyistheoverallpositiverela-htionshipbetweenserumtotalTlevelandlumbarBMDinhmiddle-agedpostmenopausalwomen,withthisassociationhbeinglinearuptoalevelof30ng/dL..erefore,increasinghtestosteroneinwomenwithlowTlevels(<30ng/dL)mayimprovebonehealthand,thus,outcomesofpostmeno-pausalosteoporosis.BonegrowthandmaintenancearesigniEcantlyinFu-encedbytestosterone,whichexertsstrongandrogenicandhanabolice3ectsinbothmena

---

### Chunk 29/30
**Article:** Association between Serum Total Testosterone Level and Bone Mineral Density in Middle-Aged Postmenopausal Women (2022)
**Journal:** International Journal of Endocrinology
**Section:** other | **Similarity:** 0.539

ewsDiseasePrimers,vol.2,no.1,ArticleID16069,2016.[3]S.Song,Y.Guo,Y.Yang,andD.Fu,“Advancesinpath-ogenesisandtherapeuticstrategiesforosteoporosis,”Pharmacology&erapeutics,vol.237,ArticleID108168,2022.[4]S.Rozenberg,N.Al-Daghri,M.Aubertin-Leheudreetal.,“Istherearoleformenopausalhormonetherapyintheman-agementofpostmenopausalosteoporosis?”OsteoporosisIn-ternational,vol.31,no.12,pp.2271–2286,2020.[5]C.H.Cheng,L.R.Chen,andK.H.Chen,“Osteoporosisduetohormoneimbalance:anoverviewofthee3ectsofestrogenhdeEciencyandglucocorticoidoveruseonboneturnover,”InternationalJournalofMolecularSciences,vol.23,no.3,p.1376,2022.[6]T.Porcelli,F.Ma3ezzoni,L.C.Pezzaioli,A.Delbarba,C.Cappelli,andA.Ferlin,“Managementofendocrinedisease:maleosteoporosis:diagnosisandmanagement-shouldthetreatmentandthetargetbethesameasforfemaleosteo-porosis?”EuropeanJournalofEndocrinology,vol.183,no.3,pp.R75–r93,2020.[7]V.Rochira,“Late-onsethypogonadism:bonehealth,”Andrology,vol.8,no.6,pp.1539–1550,2020.[8]G.Cor

---

### Chunk 30/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** discussion | **Similarity:** 0.539

salwomen,52hadosteosarcopenia(10.9%),182hadosteoporosis(38.1%),51hadsarcopenia(10.6%),and193hadnosarcopeniaandnoosteoporosis(NonSP/NonOP)(40.4%).Thesubjectswithosteosarco-peniawereolder,performedlessphysicalexerciseandconsumedlessmilk.ThesesubjectsalsohadlowerlevelsofDHEA,oxytocinand25OHD,higherlevelsoffollista-tinandmorehistoryoffragilityfracturecomparedtothesubjectsinothergroups.DHEA(32.51±12.8and34.97±16.2vs.42.64±12.8and48.45±10.6,p=0.042)wassignificantlylower,andfollistatin(18.76±4.8and18.97±6.1vs.14.93±4.0and13.0±4.9,p=0.027)wassignificantlyhigherinthesarcopeniagroupthanthere-spectivelevelsinnonsarcopeniagroup.OxytocinwaslowerinosteoporosisandsarcopeniagroupscomparedtotheNonSP/NonOPgroup,anditwasthelowestinosteosarcopeniagroup.Alogisticregressionanalysis,ad-justedforage,demonstratedthathistoryoffragilityfrac-ture(novs.fracture)(OR0.30;95%CI0.05–0.71;p=0.006)andoxytocin(OR0.75;95%CI0.63–0.98;p=0.019)wereassociatedwithosteoporosis,andhistoryoffragilityfracture(novs.frac

---

